SCHEMBL30923144

SCHEMBL30923144

COc1c(Nc2nc(Nc3ccccn3)ncc2C(N)=O)cccc1-c1ncccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 6/20 0.52
▸ JAK2 O60674 6/20 0.52
▸ JAK3 P52333 6/20 0.52
▸ JAK1 P23458 5/20 0.52
▸ SYK P43405 4/20 0.49
▸ MAPK9 P45984 3/20 0.47
▸ MAPK8 P45983 2/20 0.47
▸ CDK2 P24941 2/20 0.47
▸ CCNK O75909 1/20 0.47
▸ CCNA2 P20248 1/20 0.47
▸ CCND3 P30281 1/20 0.47
▸ CDK9 P50750 1/20 0.47
▸ CDK6 Q00534 1/20 0.47
▸ MAP4K1 Q92918 3/20 0.45
▸ MAPK10 P53779 1/20 0.45
▸ PTK2 Q05397 2/20 0.45
▸ CDC7 O00311 1/20 0.45
▸ PLK4 O00444 1/20 0.45
▸ CHEK1 O14757 1/20 0.45
▸ DCLK1 O15075 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27289879 1.00 TYK2 (0.52) TYK2JAK2JAK3JAK1SYK
SCHEMBL30923225 0.91 JAK3 (0.51) TYK2JAK2JAK3JAK1SYK
SCHEMBL27290259 0.91 JAK3 (0.51) TYK2JAK2JAK3JAK1SYK
SCHEMBL27292535 0.91 CCNK (0.47) TYK2JAK2JAK3JAK1MAPK8
SCHEMBL30923145 0.91 CCNK (0.47) TYK2JAK2JAK3JAK1MAPK8
SCHEMBL27290121 0.90 TYK2 (0.57) TYK2JAK2JAK3JAK1SYK
SCHEMBL27289976 0.90 SYK (0.47) TYK2JAK2JAK3JAK1SYK
SCHEMBL30923147 0.88 JAK2 (0.48) TYK2JAK2JAK3JAK1SYK
SCHEMBL27290899 0.88 JAK2 (0.48) TYK2JAK2JAK3JAK1SYK
SCHEMBL27290481 0.87 JAK2 (0.47) TYK2JAK2JAK3JAK1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618975-A2 INHIBITORS OF TYK2 Vyrnwy Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024107658-A2 INHIBITORS OF TYK2 VYRNWY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback